Contact A Lawyer
Near You

Contact us today for a complimentary consultation with a qualified attorney near you.

Class action suit filed over Zyprexa

-January 10, 2006

In late December, seven Illinois residents filed a lawsuit against the makers of Zyprexa, Eli Lilly & Co, for serious side effects allegedly caused by this medication. Zyprexa is approved by the FDA to treat schizophrenia and bipolar. This top-selling drug, accounting for one-third of Eli Lilly revenue, has long been associated with serious drug side effects. Each of the plaintiffs in the Zyprexa lawsuit argue that Zyprexa caused the onset of diabetes and pancreatitis.

These injured consumers argue that immediately after Eli Lilly released Zyprexa, the FDA received a high volume of adverse side effects reports-including the onset of diabetes and related health conditions-from those patients taking this drug. While Eli Lilly was well aware of Zyprexa's propensity to cause diabetes, thy failed to adequately warn consumers and doctors, argue the plaintiffs.

The complaint states the FDA informed Eli Lilly (and the manufacturers of similar medications) in September 2003 that all atypical antipsychotic medications must bear a warning about diabetes and other drug side effects on the products' labeling. Eli Lilly chose to wait until March 2004 to actually issue this warning in the form of a "Dear Doctor" letter. These Zyprexa warnings did not appear in the Physician's Desk Reference until the 2005 edition; years after the risks were discovered.

The injured Zyprexa users claim that if they had been adequately informed of the life-threatening risks associated with this medication, they would have chosen another medication to treat their condition. Each of these plaintiffs are seeking over one million dollars in damages in addition to the cost of filing the Zyprexa lawsuit.

For more information on Zyprexa side effects and lawsuit information, please contact us.

 

More Recent Defective Drug News

Contact a News Recall Lawyer